Results 191 to 200 of about 26,261 (211)

Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis

Diabetes and Vascular Disease Research, 2016
Tracey Gaspari, Anthony Edwin Dear, Robert Widdop   +2 more
exaly  

The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist

Diabetes Therapy, 2014
, Bain Stephen C
exaly  

Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes

American Journal of Obstetrics and Gynecology
Marisa Imbroane
exaly  

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes

Arthroplasty Today
Brian Muffly, Greg Erens, Jacob M Wilson   +2 more
exaly  

Glucagon-Like Peptide-1 Receptor Agonist Use Is Not Associated With Increased Complications After Total Hip Arthroplasty in Patients Who Have Type 2 Diabetes

Journal of Arthroplasty
Jacob M Wilson, Kevin Heo
exaly  

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Lancet, The, 2014
Bernard Zinman, Caroline Kramer, Ravi Retnakaran   +2 more
exaly  

Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings

Endocrine, Metabolic and Immune Disorders - Drug Targets
Şerife Mehlika Kuskonmaz, Gönül Varan Koc, Cavit Culha   +2 more
exaly  

Glucagon-like peptide-1 receptor agonists and acute pancreatitis

Diabetes & Metabolism
Kuan-Fu, Liao, Shih-Wei, Lai
openaire   +2 more sources

Glucagon-Like Peptide-1 Receptor Agonists and Cancer—Reply

JAMA Oncology
Hao, Dai, Jingchuan, Guo, Jiang, Bian
openaire   +2 more sources